Search by Drug Name or NDC
NDC 00591-4910-01 Trientine Hydrochloride 250 mg/1 Details
Trientine Hydrochloride 250 mg/1
Trientine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is TRIENTINE HYDROCHLORIDE.
Product Information
| NDC | 00591-4910 |
|---|---|
| Product ID | 0591-4910_5d9a34dd-179f-4599-8912-1714e063def6 |
| Associated GPIs | 99200020100110 |
| GCN Sequence Number | 002554 |
| GCN Sequence Number Description | trientine HCl CAPSULE 250 MG ORAL |
| HIC3 | C8A |
| HIC3 Description | METALLIC POISON,AGENTS TO TREAT |
| GCN | 00720 |
| HICL Sequence Number | 001109 |
| HICL Sequence Number Description | TRIENTINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Trientine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Trientine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRIENTINE HYDROCHLORIDE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Metal Chelating Activity [MoA], Metal Chelator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207567 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-4910-01 (00591491001)
| NDC Package Code | 0591-4910-01 |
|---|---|
| Billing NDC | 00591491001 |
| Package | 100 CAPSULE in 1 BOTTLE (0591-4910-01) |
| Marketing Start Date | 2018-02-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |